Molecules and Cells

Korean Society for Molecular and Cellular Biology (한국분자세포생물학회)
권호 표지
DOI QR코드

DOI QR Code

Synthesis of Reconstituted High Density Lipoprotein (rHDL) Containing apoA-I and apoC-III: the Functional Role of apoC-III in rHDL

  • Cho, Kyung-Hyun (School of Biotechnology, Aging-associated Vascular Disease Research Center, Yeungnam University)
  • Received : 2008.07.03
  • Accepted : 2008.12.16
  • Published : 2009.03.31
⟨ Previous Next ⟩

Abstract

Apolipoprotein (apo) C-III is a marker protein of triacylglycerol (TG)-rich lipoproteins and high-density lipoproteins (HDL), and has been proposed as a risk factor of coronary heart disease. To compare the physiologic role of reconstituted HDL (rHDL) with or without apoC-III, we synthesized rHDL with molar ratios of apoA-I:apoC-III of 1:0, 1:0.5, 1:1, and 1:2. Increasing the apoC-III content in rHDL produced smaller rHDL particles with a lower number of apoA-I molecules. Furthermore, increasing the molar ratio of apoC-III in rHDL enhanced the surfactant-like properties and the ability to lyse dimyristoyl phosphatidylcholine. Furthermore, rHDL containing apoC-III was found to be more resistant to particle rearrangement in the presence of low-density lipoprotein (LDL) than rHDL that contained apoA-I alone. In addition, the lecithin:cholesterol acyltransferase (LCAT) activation ability was reduced as the apoC-III content of the rHDL increased; however, the CE transfer ability was not decreased by the increase of apoC-III. Finally, rHDL containing apoC-III aggravated the production of MDA in cell culture media, which led to increased cellular uptake of LDL. Thus, the addition of apoC-III to rHDL induced changes in the structural and functional properties of the rHDL, especially in particle size and rearrangement and LCAT activation. These alterations may lead to beneficial functions of HDL, which is involved in anti-atherogenic properties in the circulation.

Keywords

Acknowledgement

Supported by : Korea Science and Engineering Foundation, Yeungnam University

References

  1. Barter, P.J., Nicholls, S., Rye, K.A., Anantharamaiah, G.M., Naval, M., and Fogelman, A.M. (2004). Antiinflammatory properties of HDL. Circ. Res. 9, 764-772 https://doi.org/10.1161/01.RES.0000146094.59640.13
  2. Breyer, E.D., Le, N.A., Li, X., Martinson, D., and Brown, W.V. (1999). Apolipoprotein C-III displacement of apolipoprotein E from VLDL:effect of particle size. J. Lipid Res. 40, 1875-1882
  3. Brousseau, M.E. (2005). Emerging role of high-density lipoprotein in the prevention of cardiovascular disease. Drug Discov. Today 10, 1095-1101 https://doi.org/10.1016/S1359-6446(05)03514-2
  4. Brown, M.L., Inazu, A., Hesler, C.B., Agellon, L.B., Mann, C., Whitlock, M.E., Marcel, Y.L., Milne, R.W., Koizumi, J., Mabuchi, H., et al. (1989). Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 342, 448-51 https://doi.org/10.1038/342448a0
  5. Bruns, G.A., Karathanasis, S.K., and Breslow, J.L. (1984). Human apolipoprotein A-I--C-III gene complex is located on chromosome 11. Arteriosclerosis 4, 97-102 https://doi.org/10.1161/01.ATV.4.2.97
  6. Cho, K.H., and Jonas, A. (2000). A key point mutation (V156E) affects the structure and functions of human apolipoprotein A-I. J. Biol. ChemK 275, 26821-26827 https://doi.org/10.1074/jbc.M002841200
  7. Cho, K.H., Lee, J.Y., Choi, M.S., Cho, J.M., Lim, J.S., and Park, Y.B.(1998). A peptide from hog plasma that inhibits human cholesteryl ester transfer protein. Biochim. Biophys. Acta 30, 133-144 https://doi.org/10.1016/S0005-2760(97)00197-5
  8. Cho, K.H., Shin, D.G., Baek, S.H., and Kim, J.R. (2009). Myocardial infarction patients showed altered lipoprotein properties and functions when compared with stable angina pectoris patients. Exp. Mol. Med. 41, 67-76 https://doi.org/10.3858/emm.2009.41.2.009
  9. Ginsberg, H.N., Le, N.A., Goldberg, I.J., Gibson, J.C., Rubinstein, A., Wang-Iverson, P., Norum, R., and Brown, W.V. (1986). Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J. Clin. Invest. 78, 1287-1295 https://doi.org/10.1172/JCI112713
  10. Ginsberg, H.N., Jones, J., Blaner, W.S., Thomas, A., Karmally, W., Fields, L., Blood, D., and Begg, M.D. (1995). Association of postprandial triglyceride and retinyl plalmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women. Arterioscler. Thromb. Vasc. Biol. 15, 1829-1838 https://doi.org/10.1161/01.ATV.15.11.1829
  11. Han, J.M., Jeong, T.S., Lee, W.S., Choi, I., and Cho, K.H. (2005). Structural and functional properties of V156K and A158E mutants of apolipoprotein A-I in the lipid-free and lipid-bound states. J. Lipid. Res. 46, 589-596 https://doi.org/10.1194/jlr.M400468-JLR200
  12. Hodis, H.N. (1999). Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis. Circulation 99, 2852-2854 https://doi.org/10.1161/01.CIR.99.22.2852
  13. Jonas, A. (1991). Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins. Biochim. Biophys. Acta 1084, 205-220 https://doi.org/10.1016/0005-2760(91)90062-M
  14. Jonas, A., Sweeny, S.A., and Herber, P.N. (1984). Discoidal complexes of A and C apolipoproteins with lipids and their reactions with lecithin:cholesterol acyltransferase. J. Biol. Chem. 259, 6369-6375
  15. Jonas, A., Kezdy, K.E., and Wald, J.H. (1989). Defined apolipoprotein A-I conformations in reconstituted high density lipoprotein discs. J. Biol. Chem. 264, 4818-4824
  16. Jonas, A., Wald, J.H., Toohill, K.L., Krul, E.S., and Kezdy, K.E. (1990). Apolipoprotein A-I structure and lipid properties in homogeneous, reconstituted spherical and discoidal high density lipoproteins. J. Biol. Chem. 265, 22123-22129
  17. Lee, S., Campos, H., Moye, L.A., and Sacks, F.M. (2003). LDL containing apolipoprotein C-III is an independent risk factor for coronary events in diabetic patients. Arterioscler. Thromb. Vasc. Biol. 23, 853-858 https://doi.org/10.1161/01.ATV.0000066131.01313.EB
  18. Lewis, G.F., and Rader, D.J. (2005). New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 96, 1221-1232 https://doi.org/10.1161/01.RES.0000170946.56981.5c
  19. Markwell, M.A., Haas, S.M., Bieber, L.L., and Tolbert, N.E. (1978). A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. BiochemK 87, 206-210 https://doi.org/10.1016/0003-2697(78)90586-9
  20. Matz, C.E., and Jonas, A. (1982). Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem 257, 4535-4540
  21. Nishida, H.I., Nakanishi, T., Yen, E.A., Arai, H., Yen, F.T., and Nishida, T. (1986). Nature of the enhancement of lecithincholesterol acyltransferase reaction by various apolipoproteins. J. Biol. Chem. 261, 12028-12035
  22. Onat, A., Hergenc, G., Sansoy, V., Fobker, M., Ceyhan, K., Toprak, S., and Assmann, G. (2003). Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders. Atherosclerosis 168, 81-89 https://doi.org/10.1016/S0021-9150(03)00025-X
  23. Ooi, E.M.M., Barrett, P.H.R., Chan, D.C., and Watts, G.F. (2008). Apolipoprotein C-III:understanding an emerging cardiovascular risk factor. Clin. Sci. 114, 611-624 https://doi.org/10.1042/CS20070308
  24. Park, S.H., Park, J.E., Kim, Y.O., Song, K.J., Kim, S.S., Kim, J.R., Choi, I., Kim, J.J., and Cho, K.H. (2008). Function and composition of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients. Clin. Biochem. 41, 56-64 https://doi.org/10.1016/j.clinbiochem.2007.10.007
  25. Pownall, H.J., Massey, J.B., Kusserow, S.K., and Gotto, A.M., Jr. (1978). Kinetics of lipid-protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines. Biochemistry 17, 1183-1188 https://doi.org/10.1021/bi00600a008
  26. Sacks, F.M., Alaupovic, P., Moye, L.A., Cole, T.G., Sussex, B., Stampfer, M.J., Pfeffer, M.A., and Braunwald, E. (2000). VLDL, Apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the cholesterol and recurrent events (CARE). Trial. Circulation 102, 1886-1892 https://doi.org/10.1161/01.CIR.102.16.1886
  27. Shachter, N.S. (2001). Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr. Opin. Lipidol. 12, 297-304 https://doi.org/10.1097/00041433-200106000-00009
  28. Sparks, D.L., and Pritchard, P.H. (1989). Transfer of cholesteryl ester into high density lipoprotein by cholesteryl ester transfer protein: effect of HDL lipid and apoprotein content. J. Lipid. Res. 30, 1491-1498
  29. Staros, J.V. (1982). N-hydroxysulfosuccinimide active esters: bis Nhydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers. Biochemistry 21, 3950-3955 https://doi.org/10.1021/bi00260a008
  30. Ting, H.J., Stice, J.P., Schaff, U.Y., Hui, D.Y., Rutledge, J.C., Knowlton, A.A., Passerini, A.G., and Simon, S.I. (2007). Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha. Circ. Res. 100, 381-390 https://doi.org/10.1161/01.RES.0000258023.76515.a3
  31. Wang, C.S., McConathy, W.J., Kloer, H.U., and Alaupovic, P. (1985). Modulation of lipoprotein lipase activity by apolipoproteins. J. Clin. Invest. 75, 384-390 https://doi.org/10.1172/JCI111711

Cited by

  1. Biomedicinal implications of high-density lipoprotein: its composition, structure, functions, and clinical applications vol.42, pp.7, 2009, https://doi.org/10.5483/bmbrep.2009.42.7.393
  2. Inhibition of collar-induced carotid atherosclerosis by recombinant apoA-I cysteine mutants in apoE-deficient mice vol.51, pp.12, 2010, https://doi.org/10.1194/jlr.m008573
  3. Severely modified lipoprotein properties without a change in cholesteryl ester transfer protein activity in patients with acute renal failure secondary to Hantaan virus infection vol.43, pp.8, 2009, https://doi.org/10.5483/bmbrep.2010.43.8.535
  4. Effect in vitro of apolipoprotein A-V on the structure and functions of recombinant high density lipoprotein vol.401, pp.3, 2009, https://doi.org/10.1016/j.bbrc.2010.09.084
  5. Modified apolipoprotein (apo) A-I by artificial sweetener causes severe premature cellular senescence and atherosclerosis with impairment of functional and structural properties of apoA-I in lipid-fre vol.31, pp.5, 2011, https://doi.org/10.1007/s10059-011-1009-3
  6. Enhanced Delivery of Rapamycin by V156K-apoA-I High-Density Lipoprotein Inhibits Cellular Proatherogenic Effects and Senescence and Promotes Tissue Regeneration vol.66, pp.12, 2011, https://doi.org/10.1093/gerona/glr169
  7. Turmeric and Laurel Aqueous Extracts Exhibit In Vitro Anti-Atherosclerotic Activity and In Vivo Hypolipidemic Effects in a Zebrafish Model vol.14, pp.3, 2009, https://doi.org/10.1089/jmf.2009.1389
  8. Water extracts of cinnamon and clove exhibits potent inhibition of protein glycation and anti-atherosclerotic activity in vitro and in vivo hypolipidemic activity in zebrafish vol.49, pp.7, 2011, https://doi.org/10.1016/j.fct.2011.03.043
  9. A zebrafish model for the rapid evaluation of pro-oxidative and inflammatory death by lipopolysaccharide, oxidized low-density lipoproteins, and glycated high-density lipoproteins vol.31, pp.6, 2009, https://doi.org/10.1016/j.fsi.2011.08.006
  10. A proteoliposome containing apolipoprotein A-I mutant (V156K) enhances rapid tumor regression activity of human origin oncolytic adenovirus in tumor-bearing zebrafish and mice vol.34, pp.2, 2009, https://doi.org/10.1007/s10059-012-2291-4
  11. Females with angina pectoris have altered lipoprotein metabolism with elevated cholesteryl ester transfer protein activity and impaired high-density lipoproteins-associated antioxidant enzymes vol.29, pp.4, 2009, https://doi.org/10.3892/ijmm.2011.874
  12. Grape skin and loquat leaf extracts and acai puree have potent anti-atherosclerotic and anti-diabetic activity in vitro and in vivo in hypercholesterolemic zebrafish vol.30, pp.3, 2009, https://doi.org/10.3892/ijmm.2012.1045
  13. Association Between Lipids, Lipoproteins Composition of HDL Particles and Triglyceride-Rich Lipoproteins, and LCAT and CETP Activity in Post-renal Transplant Patients vol.67, pp.2, 2009, https://doi.org/10.1007/s12013-013-9559-y
  14. Bovine apolipoprotein (apo)A-I displays more enhanced antioxidant and anti-atherosclerotic activity in lipid-free and lipid-bound states than human and porcine apoA-I vol.32, pp.4, 2009, https://doi.org/10.3892/ijmm.2013.1473
  15. Evolving targets for lipid-modifying therapy vol.6, pp.10, 2014, https://doi.org/10.15252/emmm.201404000
  16. Incorporation of Human Growth Hormone-2 into Proteoliposome Enhances Tissue Regeneration with Anti-Oxidant and Anti-Senescence Activities vol.18, pp.1, 2009, https://doi.org/10.1089/rej.2014.1594
  17. Reconstituted High-Density Lipoprotein Containing Human Growth Hormone-1 Shows Potent Tissue Regeneration Activity with Enhancement of Anti-Oxidant and Anti-Atherosclerotic Activities vol.18, pp.3, 2015, https://doi.org/10.1089/rej.2014.1644
  18. Enhancement of High-Density Lipoprotein Cholesterol Functions by Encapsulation of Policosanol Exerts Anti-Senescence and Tissue Regeneration Effects Via Improvement of Anti-Glycation, Anti-Apoptosis, vol.19, pp.1, 2016, https://doi.org/10.1089/rej.2015.1712
  19. Anti-Aging and Tissue Regeneration Ability of Policosanol Along with Lipid-Lowering Effect in Hyperlipidemic Zebrafish via Enhancement of High-Density Lipoprotein Functionality vol.19, pp.2, 2016, https://doi.org/10.1089/rej.2015.1745
  20. Development of Antisense Drugs for Dyslipidemia vol.23, pp.9, 2009, https://doi.org/10.5551/jat.rv16001
  21. Apolipoprotein C-III Nanodiscs Studied by Site-Specific Tryptophan Fluorescence vol.55, pp.35, 2009, https://doi.org/10.1021/acs.biochem.6b00599
  22. Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process vol.11, pp.10, 2009, https://doi.org/10.1371/journal.pone.0164564
  23. Altered lipoproteins in patients with systemic lupus erythematosus are associated with augmented oxidative stress: a potential role in atherosclerosis vol.18, pp.None, 2009, https://doi.org/10.1186/s13075-016-1204-x
  24. Impaired Antioxidant Ability of HDL and More Oxidized LDL are associated with Male Patients with Atrial Fibrillation vol.5, pp.2, 2016, https://doi.org/10.12997/jla.2016.5.2.145
  25. Consumption of policosanol enhances HDL functionality via CETP inhibition and reduces blood pressure and visceral fat in young and middle-aged subjects vol.39, pp.4, 2009, https://doi.org/10.3892/ijmm.2017.2907
  26. The Ability of Different Ketohexoses to Alter Apo-A-I Structure and Function In Vitro and to Induce Hepatosteatosis, Oxidative Stress, and Impaired Plasma Lipid Profile in Hyperlipidemic Zebrafish vol.2018, pp.None, 2009, https://doi.org/10.1155/2018/3124364
  27. Consumption of Cuban Policosanol Improves Blood Pressure and Lipid Profile via Enhancement of HDL Functionality in Healthy Women Subjects: Randomized, Double-Blinded, and Placebo-Controlled Study vol.2018, pp.None, 2009, https://doi.org/10.1155/2018/4809525
  28. Slim Body Weight Is Highly Associated With Enhanced Lipoprotein Functionality, Higher HDL-C, and Large HDL Particle Size in Young Women vol.9, pp.None, 2009, https://doi.org/10.3389/fendo.2018.00406
  29. Blood Pressure Lowering Effect of Cuban Policosanol is Accompanied by Improvement of Hepatic Inflammation, Lipoprotein Profile, and HDL Quality in Spontaneously Hypertensive Rats vol.23, pp.5, 2009, https://doi.org/10.3390/molecules23051080
  30. Cuban Sugar Cane Wax Acid and Policosanol Showed Similar Atheroprotective Effects with Inhibition of LDL Oxidation and Cholesteryl Ester Transfer via Enhancement of High-Density Lipoproteins Functiona vol.2019, pp.None, 2009, https://doi.org/10.1155/2019/8496409
  31. Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease vol.18, pp.1, 2009, https://doi.org/10.1186/s12944-019-1166-5
  32. Structural and Functional Impairments of Reconstituted High-Density Lipoprotein by Incorporation of Recombinant β-Amyloid42 vol.26, pp.14, 2009, https://doi.org/10.3390/molecules26144317